FDA Advisory Panel to Review Concerns Over Abbott’s Trilipix

首页> 外文期刊>Washington Drug Letter >FDA Advisory Panel to Review Concerns Over Abbott’s Trilipix

【24h】

FDA Advisory Panel to Review Concerns Over Abbott’s Trilipix

机译：FDA顾问委员会将审查有关雅培Trilipix的担忧

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

An FDA advisory panel meeting in May to review Abbott’s Trilipix could lead to labeling changes for the cholesterol-lowering drug.

机译：FDA于5月召开的一次咨询小组会议，对雅培的Trilipix进行了审查，这可能导致降低胆固醇药物的标签变更。

著录项

来源
《Washington Drug Letter》 |2011年第18期|p.1|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. FDA Panel Recommends New Study for Abbott’s Trilipix [J] . Molly Cohen Washington Drug Letter . 2011,第21期

机译：FDA小组推荐雅培Trilipix的新研究
2. Advisory Panel Likes Adcetris But Panel, FDA Voice Trial Concerns [J] . Washington Drug Letter . 2011,第28期

机译：顾问小组喜欢Adcetris，但FDA语音试验关注小组
3. FDA Panel Split on Keeping Abbott's Meridia on the Market [J] . LaCrisha Butler Washington Drug Letter . 2010,第37期

机译：FDA小组就将雅培的子午线留在市场上进行了辩论
4. "Industry Advisory Committees’ support to University IE Departments” – a panel discussion (sponsored by IIE’s Industry Advisory Board) [C] . Institute of Industrial Engineers annual conference and expo . 2009

机译：“行业咨询委员会支持大学即部门” - 小组讨论（由IIE的行业咨询委员会赞助）
5. A review of National Advertising Review Board (NARB) panel decisions from 1971 to 2009: A review of panel decisions by substantiation, print or broadcast medium and product category [D] . Powviriya, Jessica 2011

机译：审查1971年至2009年的国家广告审查委员会（NARB）小组决定：按证据，印刷或广播媒体和产品类别对小组决定进行审查
6. FDA advisory panel calls for suicide warnings over new antidepressants [O] . Ray Moynihan 2004

机译：FDA咨询小组呼吁对新型抗抑郁药提出自杀警告
7. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)44The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur.55This document was approved by the American College of Cardiology Foundation Board of Trustees in July, 2003, the American Heart Association Science Advisory and Coordinating Committee in July, 2003, and the American Society of Nuclear Cardiology Board of Directors in July, 2003.66When citing this document, the American College of Cardiology Foundation, the American Heart Association, and the American Society of Nuclear Cardiology request that the following citation format be used: Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, Kennedy JW, Lorell BH, Messer JV, O’Gara PT, Russell RO Jr, St. John Sutton MG, Udelson JE, Verani MS, Williams KA. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318–33.77(J Am Coll Cardiol 2003;42:1318–33)88©2003 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Klocke Francis J, Baird Michael G, Lorell Beverly H, 2003

机译：ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / ASNC委员会，对1995年临床使用指南进行修订ACC / AHA实践指导小组）竭尽全力避免由于写作小组成员的外部关系或个人利益而引起的任何实际或潜在的利益冲突。具体来说，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审查，在第一次会议上向书面小组的所有成员口头报告，并在发生变化时进行更新。55本文件于2003年7月获得美国心脏病学会基金会董事会的批准。 2003年7月，美国心脏协会科学咨询与协调委员会，2003年7月，美国核心脏病学会理事会。66引用该文件时，美国心脏病学会基金会，美国心脏协会和美国核学会心脏病学要求使用以下引用格式：Klocke FJ，Baird MG，Bateman TM，Berman DS，Carabello BA，Cerqueira MD，DeMaria AN，Kennedy JW，Lorell BH，Messer JV，O'Gara PT，Russell RO Jr，St John Sutton MG，Udelson JE，Verani MS，Williams KA。 ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要：美国心脏病学会/美国心脏协会实践小组工作指南（ACC / AHA / ASNC委员会，修订1995年临床指南）的报告使用放射性核素成像）。 J Am Coll Cardiol 2003; 42：1318–33.77（J Am Coll Cardiol 2003; 42：1318–33）88©2003美国心脏病学会基金会和美国心脏协会版权所有。

FDA Advisory Panel to Review Concerns Over Abbott’s Trilipix

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅